Literature DB >> 3016415

A comparative study of free radical scavengers in cardioplegic solutions. Improved protection with peroxidase.

P Menasche, C Grousset, Y Gauduel, A Piwnica.   

Abstract

Oxygen-derived free radicals play an important role in the myocardial injury associated with ischemia and reperfusion. This study was designed to assess whether the protection afforded by a K+ rich, Mg2+ rich cardioplegic solution could be enhanced by the addition of free radical scavengers acting at different levels of the radical generating pathway. Forty isolated isovolumic rat hearts were divided into five groups (n = 8). Four groups of hearts were subjected to 90 minutes of normothermic cardioplegic arrest followed by 45 minutes of reperfusion. Hearts were given an initial bolus of either unmodified cardioplegic solution or cardioplegic solution enriched with superoxide dismutase (200,000 U/L) reduced glutathione (0.1 mmol/L), or peroxidase (6,000 U/L). One group of hearts was aerobically perfused throughout the experimental protocol and served as nonischemic controls. Based on comparisons of postreperfusion ventricular pressure development, maximal ventricular dP/dt, left ventricular compliance and coronary flow, peroxidase-containing cardioplegic solution afforded the best myocardial protection, with values of these indicators not significantly different from those of nonischemic perfused control heart. Glutathione afforded protection slightly inferior to that of peroxidase but still markedly better than in groups receiving superoxide dismutase or unmodified cardioplegic solution. This study confirms that cardioplegic protection can be enhanced by the addition of free radical scavengers, in particular peroxidase.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3016415

Source DB:  PubMed          Journal:  J Thorac Cardiovasc Surg        ISSN: 0022-5223            Impact factor:   5.209


  10 in total

1.  Adding ROS quenchers to cold K+ cardioplegia reduces superoxide emission during 2-hour global cold cardiac ischemia.

Authors:  Mohammed Aldakkak; David F Stowe; James S Heisner; Matthias L Riess; Amadou K S Camara
Journal:  J Cardiovasc Pharmacol Ther       Date:  2011-01-31       Impact factor: 2.457

2.  Role of leucocytes in free radical production during myocardial revascularisation.

Authors:  E De Vecchi; R Paroni; M G Pala; G Di Credico; V Agape; C Gobbi; P A Bonini; G Paolini; A Grossi
Journal:  Heart       Date:  1997-05       Impact factor: 5.994

3.  The addition of glutathione (YM737) to a crystalloid cardioplegic solution enhances myocardial protection.

Authors:  H Okada; H Tsuboi; K Esato
Journal:  Surg Today       Date:  1994       Impact factor: 2.549

4.  Deferoxamine reduces the reperfusion injury in isolated neonatal rabbit hearts after hypothermic preservation.

Authors:  S Katoh; J Toyama; I Kodama; K Kamiya; T Akita; T Abe
Journal:  Surg Today       Date:  1993       Impact factor: 2.549

Review 5.  Stunning: a radical re-view.

Authors:  D J Hearse
Journal:  Cardiovasc Drugs Ther       Date:  1991-10       Impact factor: 3.727

Review 6.  Oxygen-derived free radicals and myocardial reperfusion injury: an overview.

Authors:  R Bolli
Journal:  Cardiovasc Drugs Ther       Date:  1991-03       Impact factor: 3.727

7.  Effect of vitamins A and E on ischemia-reperfusion damage in rabbit heart.

Authors:  S Llesuy; J Milei; V Picone; B González Flecha; R Beigelman; A Boveris
Journal:  Mol Cell Biochem       Date:  1995-04-12       Impact factor: 3.396

8.  The effect of superoxide dismutase and catalase on myocardial reperfusion injury in the isolated rat heart.

Authors:  Y Nishikawa; S Yamamoto; K Ataka; K Nakamura
Journal:  Jpn J Surg       Date:  1991-07

Review 9.  Drug antioxidant effects. A basis for drug selection?

Authors:  B Halliwell
Journal:  Drugs       Date:  1991-10       Impact factor: 9.546

10.  Q10 supplementation effects on cardiac enzyme CK-MB and troponin in patients undergoing coronary artery bypass graft: a randomized, double-blinded, placebo-controlled clinical trial.

Authors:  Jalal Moludi; Seyedali Keshavarz; Ali Sadeghpour Tabaee; Saeid Safiri; Reza Pakzad
Journal:  J Cardiovasc Thorac Res       Date:  2016-03-14
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.